Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

8.210 -0.090 (-1.08%)
Streaming Delayed Price Updated: 3:02 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 112,775
Open 8.390
Bid (Size) 8.200 (200)
Ask (Size) 8.220 (100)
Prev. Close 8.300
Today's Range 8.130 - 8.410
52wk Range 2.590 - 12.23
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Exagen (XGN) Q2 2026 Earnings Call Transcript ↗
Record revenue and near break-even adjusted EBITDA signal progress toward profitability. 
Via The Motley Fool
Topics Earnings Economy
News headline image
Exagen Q2 Earnings Call Highlights ↗
Exagen (NASDAQ:XGN) reported record second-quarter revenue as growth in AVISE CTD test volume, average selling price and Pharma Services revenue brought the autoimmune diagnostics company close to... 
Via MarketBeat
Topics Artificial Intelligence Earnings

Performance

YTD
+35.9%
+35.9%
1 Month
+11.9%
+11.9%
3 Month
+76.6%
+76.6%
6 Month
+173.7%
+173.7%
1 Year
-23.8%
-23.8%

More News

Read More
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Exagen (NASDAQ:XGN) Beats Q2 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally ↗
Via Chartmill
Topics Earnings
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
Top movers in Tuesday's session ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Exagen Inc. Reports Second Quarter 2026 Financial Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conference
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Second Quarter Financial Results on August 4, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen (XGN) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Exagen Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Exagen Inc. Reports First Quarter 2026 Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Announces Select Preliminary 2025 Financial Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗
Via Chartmill
News headline image
Exagen Inc. Reports Strong Q3 2025 Results
From Exagen Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Exagen Inc. - Common Stock publicly traded?
Yes, Exagen Inc. - Common Stock is publicly traded.
What exchange does Exagen Inc. - Common Stock trade on?
Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exagen Inc. - Common Stock?
The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
What is the current price of Exagen Inc. - Common Stock?
The current price of Exagen Inc. - Common Stock is 8.210
When was Exagen Inc. - Common Stock last traded?
The last trade of Exagen Inc. - Common Stock was at 09/30/26 03:02 PM ET
What is the market capitalization of Exagen Inc. - Common Stock?
The market capitalization of Exagen Inc. - Common Stock is 132.40M
How many shares of Exagen Inc. - Common Stock are outstanding?
Exagen Inc. - Common Stock has 132M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.